Sabre Corpo Stock Buy Hold or Sell Recommendation
| SABR Stock | USD 3.33 0.12 3.74% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Sabre Corpo is 'Sell'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell Sabre Corpo within the specified time frame.
Check out Sabre Corpo Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Sabre Stock, please use our How to Invest in Sabre Corpo guide. Note, we conduct extensive research on individual companies such as Sabre and provide practical buy, sell, or hold advice based on investors' constraints. Sabre Corpo. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Sabre |
Execute Sabre Corpo Buy or Sell Advice
The Sabre recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Sabre Corpo. Macroaxis does not own or have any residual interests in Sabre Corpo or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Sabre Corpo's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Unstable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Sabre Corpo Trading Alerts and Improvement Suggestions
| Sabre Corpo generated a negative expected return over the last 90 days | |
| Sabre Corpo has high historical volatility and very poor performance | |
| Sabre Corpo has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 3.03 B. Net Loss for the year was (278.76 M) with profit before overhead, payroll, taxes, and interest of 1.79 B. | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from businesswire.com: Pison Presents Research Findings at the SABR Conference Correlating Cognitive Assessments to On-field Baseball Performance |
Sabre Corpo Returns Distribution Density
The distribution of Sabre Corpo's historical returns is an attempt to chart the uncertainty of Sabre Corpo's future price movements. The chart of the probability distribution of Sabre Corpo daily returns describes the distribution of returns around its average expected value. We use Sabre Corpo price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Sabre Corpo returns is essential to provide solid investment advice for Sabre Corpo.
| Mean Return | -0.1 | Value At Risk | -5.05 | Potential Upside | 4.53 | Standard Deviation | 4.07 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Sabre Corpo historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Sabre Stock Institutional Investors
The Sabre Corpo's institutional investors refer to entities that pool money to purchase Sabre Corpo's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Geode Capital Management, Llc | 2024-12-31 | 9.1 M | Hill City Capital, Lp | 2024-12-31 | 6.6 M | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 6.5 M | Arrowstreet Capital Limited Partnership | 2024-12-31 | 5.9 M | Us Global Investors Inc | 2024-12-31 | 5.6 M | Charles Schwab Investment Management Inc | 2024-12-31 | 5.5 M | Northern Trust Corp | 2024-12-31 | 4.6 M | Goldman Sachs Group Inc | 2024-12-31 | 3.9 M | Two Sigma Advisers, Llc | 2024-12-31 | 3.7 M | Blackrock Inc | 2024-12-31 | 59.7 M | Vanguard Group Inc | 2024-12-31 | 40.9 M |
Sabre Corpo Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | 33.9M | 99.1M | (52.5M) | 47.5M | 54.7M | 57.4M | |
| Change In Cash | 1.1B | (500.3M) | (183.5M) | (146.7M) | 76.3M | 80.1M | |
| Free Cash Flow | (838.6M) | (472.5M) | (349.2M) | (31.6M) | (13.6M) | (12.9M) | |
| Depreciation | 363.7M | 262.2M | 184.6M | 148.7M | 129.5M | 243.9M | |
| Other Non Cash Items | 240.6M | 74.0M | (73.4M) | 224.3M | (56.1M) | (53.3M) | |
| Dividends Paid | 153.5M | 44.4M | 21.6M | 21.4M | 16.0M | 0.0 | |
| Capital Expenditures | 65.4M | 54.3M | 69.5M | 87.4M | 84.1M | 140.4M | |
| Net Income | (1.3B) | (926.3M) | (432.8M) | (527.9M) | (278.8M) | (292.7M) | |
| End Period Cash Flow | 1.5B | 999.4M | 815.9M | 669.2M | 745.5M | 553.5M | |
| Investments | 2.5M | 24.9M | 174.0M | (92.9M) | (29.6M) | (28.1M) | |
| Change Receivables | (33.9M) | 205.0M | (17.9M) | (122.3M) | (110.1M) | (104.6M) | |
| Net Borrowings | (61.6M) | 1.4B | 6.8M | (37.6M) | (43.2M) | (41.0M) | |
| Change To Netincome | 66.0M | 122.0M | 97.8M | (76.0M) | (87.4M) | (83.1M) |
Sabre Corpo Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Sabre Corpo or Professional Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Sabre Corpo's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Sabre stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.07 | |
β | Beta against Dow Jones | 0.36 | |
σ | Overall volatility | 4.12 | |
Ir | Information ratio | 0.0001 |
Sabre Corpo Volatility Alert
Sabre Corpo exhibits very low volatility with skewness of 2.58 and kurtosis of 13.77. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Sabre Corpo's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Sabre Corpo's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Sabre Corpo Fundamentals Vs Peers
Comparing Sabre Corpo's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Sabre Corpo's direct or indirect competition across all of the common fundamentals between Sabre Corpo and the related equities. This way, we can detect undervalued stocks with similar characteristics as Sabre Corpo or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Sabre Corpo's fundamental indicators could also be used in its relative valuation, which is a method of valuing Sabre Corpo by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Sabre Corpo to competition |
| Fundamentals | Sabre Corpo | Peer Average |
| Return On Equity | -7.37 | -0.31 |
| Return On Asset | 0.0435 | -0.14 |
| Profit Margin | (0.09) % | (1.27) % |
| Operating Margin | 0.08 % | (5.51) % |
| Current Valuation | 5.68 B | 16.62 B |
| Shares Outstanding | 386.07 M | 571.82 M |
| Shares Owned By Insiders | 2.76 % | 10.09 % |
| Shares Owned By Institutions | 97.75 % | 39.21 % |
| Number Of Shares Shorted | 17.56 M | 4.71 M |
| Price To Earning | 26.39 X | 28.72 X |
| Price To Book | 145.10 X | 9.51 X |
| Price To Sales | 0.42 X | 11.42 X |
| Revenue | 3.03 B | 9.43 B |
| Gross Profit | 1.79 B | 27.38 B |
| EBITDA | 358.67 M | 3.9 B |
| Net Income | (278.76 M) | 570.98 M |
| Cash And Equivalents | 786.61 M | 2.7 B |
| Cash Per Share | 2.40 X | 5.01 X |
| Total Debt | 5.06 B | 5.32 B |
| Current Ratio | 1.89 X | 2.16 X |
| Book Value Per Share | (4.20) X | 1.93 K |
| Cash Flow From Operations | 70.59 M | 971.22 M |
| Short Ratio | 4.11 X | 4.00 X |
| Earnings Per Share | (0.73) X | 3.12 X |
| Price To Earnings To Growth | 1.36 X | 4.89 X |
| Target Price | 4.99 | |
| Number Of Employees | 6.25 K | 18.84 K |
| Beta | 1.63 | -0.15 |
| Market Capitalization | 1.29 B | 19.03 B |
| Total Asset | 4.63 B | 29.47 B |
| Retained Earnings | (4.33 B) | 9.33 B |
| Working Capital | 21.44 M | 1.48 B |
| Current Asset | 778.09 M | 9.34 B |
Note: Insider Trading [view details]
Sabre Corpo Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Sabre . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Sabre Corpo Buy or Sell Advice
When is the right time to buy or sell Sabre Corpo? Buying financial instruments such as Sabre Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Sabre Corpo in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Treasury ETFs Thematic Idea Now
Treasury ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Treasury ETFs theme has 124 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Treasury ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Sabre Stock Analysis
When running Sabre Corpo's price analysis, check to measure Sabre Corpo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabre Corpo is operating at the current time. Most of Sabre Corpo's value examination focuses on studying past and present price action to predict the probability of Sabre Corpo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabre Corpo's price. Additionally, you may evaluate how the addition of Sabre Corpo to your portfolios can decrease your overall portfolio volatility.